+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Equine Veterinary Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company)

  • PDF Icon

    Report

  • 155 Pages
  • January 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 6052155
Description Jump to:
The global equine veterinary therapeutics market is set to witness substantial expansion, driven by increasing awareness of animal health and advancements in treatment technologies. The market is projected to reach USD 1.612 billion in 2025 and is expected to grow significantly, reaching USD 3.26 billion by 2032 at a CAGR of 10.61% during the forecast period. The increasing focus on preventive care and specialized veterinary services for horses is fueling market growth worldwide.

Market Insights

Equine healthcare encompasses the diagnosis, treatment, and management of various health conditions affecting horses. Rising trends in equestrian sports, horse breeding, and increasing concerns over equine diseases are contributing to the growing demand for equine veterinary therapeutics. Key advancements in pain management, regenerative medicine, and non-invasive treatments are revolutionizing the industry, offering new opportunities for growth.

Market Growth Drivers

  • Increasing Human Affinity for Horses - The growing popularity of horse ownership, particularly for recreational and sports purposes, is driving the demand for effective veterinary care.
  • Rising Awareness About Animal Health - With growing awareness about equine diseases, vaccinations, and advanced treatment options, horse owners and equestrian professionals are prioritizing preventive healthcare.
  • Expanding Equestrian Sports Business - The surge in horse racing, show jumping, and dressage events is boosting the need for specialized equine veterinary services to ensure optimal performance and longevity.
  • Technological Advancements in Veterinary Medicine - The introduction of telemedicine, wearable monitoring devices, and innovative drug formulations is enhancing treatment precision and effectiveness.

Business Opportunities

  • Innovations in Regenerative Medicine - The increasing adoption of stem cell therapy and platelet-rich plasma (PRP) treatment for musculoskeletal injuries presents new growth avenues.
  • Expansion in Emerging Markets - Growing investments in equine healthcare in Asia Pacific and Latin America highlight untapped potential for veterinary therapeutic companies.
  • Rise in Equestrian Rehabilitation Centers - The increasing establishment of rehabilitation centers for injured horses is generating demand for advanced veterinary solutions and specialized care.

Regional Analysis

North America: Market Leader with Advanced Veterinary Infrastructure

North America dominates the equine veterinary therapeutics market due to widespread equestrian activities, a high number of horse farms, and increasing veterinary expenditures. The region has an established infrastructure for equine healthcare, including research institutions and veterinary hospitals.

Europe: Growing Demand for Veterinary Services

With rising pet ownership and strong governmental initiatives for animal health and welfare, Europe is witnessing growing demand for equine healthcare solutions. The emphasis on disease prevention and control measures supports the regional market expansion.

Asia Pacific: Lucrative Growth Potential

The Asia Pacific region is emerging as a high-growth market, driven by increasing investments in animal healthcare and rising demand for medicinal feeds. Countries like China and India are experiencing a surge in equestrian sports, further fueling the market.

Latin America and Middle East & Africa: Developing Equine Healthcare Infrastructure

While these regions currently hold a smaller market share, increasing awareness and investments in animal health are expected to drive significant growth in the coming years.

Key Players

Leading companies in the equine veterinary therapeutics market are actively engaging in research and development, product innovations, and strategic collaborations to enhance their market presence. Key industry players include.
  • Merck Animal Health
  • Affymetrix
  • Elanco Animal Health
  • Zoetis (Pfizer Animal Health)
  • Equine Health UK

Recent Industry Developments

Intra-Articular Bone Marrow Mononuclear Cell (BMNC) Therapy

A breakthrough in equine osteoarthritis treatment, BMNC therapy has demonstrated significant improvements in clinical signs, including reduced joint inflammation and enhanced mobility. This innovation is expected to revolutionize equine pain management and rehabilitation.

Equine-Assisted Therapy for Children

Programs such as iTalk with Horses are integrating equine-assisted therapy for speech and cognitive development in children. This initiative highlights the growing role of horses in therapeutic and rehabilitative practices beyond sports.

Competitive Analysis

Companies are investing in product innovation, mergers, and strategic collaborations to expand their market reach. Key strategies include.
  • Increasing R&D investments for novel therapeutics
  • Expanding production facilities to enhance supply chain efficiency
  • Strengthening partnerships with equestrian organizations to improve service accessibility

Market Segmentation

The market is segmented based on drug type, route of administration, services, distribution channels, and regions:

By Drugs:

  • Anti-Inflammatory
  • Anti-Infective
  • Parasiticides
  • Others

By Route of Administration:

  • Oral
  • Parenteral
  • Topical

By Services:

  • Diagnostic Tests and Imaging
  • Physical Health Monitoring
  • Surgery
  • Vaccination
  • Others

By Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies and Drug Stores
  • E-commerce
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Equine Veterinary Therapeutics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Equine Veterinary Therapeutics Market Outlook, 2019 - 2032
3.1. Global Equine Veterinary Therapeutics Market Outlook, by Drugs, Value (US$ Bn), 2019 - 2032
3.1.1. Key Highlights
3.1.1.1. Anti-Infammatory
3.1.1.2. Anti-infective
3.1.1.3. Parasiticides
3.1.1.4. Others
3.2. Global Equine Veterinary Therapeutics Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2032
3.2.1. Key Highlights
3.2.1.1. Oral
3.2.1.2. Parental
3.2.1.3. Topical
3.3. Global Equine Veterinary Therapeutics Market Outlook, by Service, Value (US$ Bn), 2019 - 2032
3.3.1. Key Highlights
3.3.1.1. Diagnostic tests and Imaging
3.3.1.2. Physical Health Monitoring
3.3.1.3. Surgery
3.3.1.4. Vaccination
3.3.1.5. Others
3.4. Global Equine Veterinary Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2032
3.4.1. Key Highlights
3.4.1.1. Veterinary Hospitals
3.4.1.2. Veterinary Clinics
3.4.1.3. Pharmacies and Drug Stores
3.4.1.4. E-commerce
3.4.1.5. Others
3.5. Global Equine Veterinary Therapeutics Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Equine Veterinary Therapeutics Market Outlook, 2019 - 2032
4.1. North America Equine Veterinary Therapeutics Market Outlook, by Drugs, Value (US$ Bn), 2019 - 2032
4.1.1. Key Highlights
4.1.1.1. Anti-Infammatory
4.1.1.2. Anti-infective
4.1.1.3. Parasiticides
4.1.1.4. Others
4.2. North America Equine Veterinary Therapeutics Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2032
4.2.1. Key Highlights
4.2.1.1. Oral
4.2.1.2. Parental
4.2.1.3. Topical
4.3. North America Equine Veterinary Therapeutics Market Outlook, by Service, Value (US$ Bn), 2019 - 2032
4.3.1. Key Highlights
4.3.1.1. Diagnostic tests and Imaging
4.3.1.2. Physical Health Monitoring
4.3.1.3. Surgery
4.3.1.4. Vaccination
4.3.1.5. Others
4.4. North America Equine Veterinary Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2032
4.4.1. Key Highlights
4.4.1.1. Veterinary Hospitals
4.4.1.2. Veterinary Clinics
4.4.1.3. Pharmacies and Drug Stores
4.4.1.4. E-commerce
4.4.1.5. Others
4.5. North America Equine Veterinary Therapeutics Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
4.5.1. Key Highlights
4.5.1.1. U.S. Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
4.5.1.2. U.S. Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
4.5.1.3. U.S. Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
4.5.1.4. U.S. Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
4.5.1.5. Canada Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
4.5.1.6. Canada Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
4.5.1.7. Canada Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
4.5.1.8. Canada Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Equine Veterinary Therapeutics Market Outlook, 2019 - 2032
5.1. Europe Equine Veterinary Therapeutics Market Outlook, by Drugs, Value (US$ Bn), 2019 - 2032
5.1.1. Key Highlights
5.1.1.1. Anti-Infammatory
5.1.1.2. Anti-infective
5.1.1.3. Parasiticides
5.1.1.4. Others
5.2. Europe Equine Veterinary Therapeutics Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2032
5.2.1. Key Highlights
5.2.1.1. Oral
5.2.1.2. Parental
5.2.1.3. Topical
5.3. Europe Equine Veterinary Therapeutics Market Outlook, by Service, Value (US$ Bn), 2019 - 2032
5.3.1. Key Highlights
5.3.1.1. Diagnostic tests and Imaging
5.3.1.2. Physical Health Monitoring
5.3.1.3. Surgery
5.3.1.4. Vaccination
5.3.1.5. Others
5.4. Europe Equine Veterinary Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2032
5.4.1. Key Highlights
5.4.1.1. Veterinary Hospitals
5.4.1.2. Veterinary Clinics
5.4.1.3. Pharmacies and Drug Stores
5.4.1.4. E-commerce
5.4.1.5. Others
5.5. Europe Equine Veterinary Therapeutics Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
5.5.1. Key Highlights
5.5.1.1. Germany Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
5.5.1.2. Germany Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
5.5.1.3. Germany Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
5.5.1.4. Germany Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
5.5.1.5. U.K. Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
5.5.1.6. U.K. Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
5.5.1.7. U.K. Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
5.5.1.8. U.K. Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
5.5.1.9. France Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
5.5.1.10. France Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
5.5.1.11. France Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
5.5.1.12. France Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
5.5.1.13. Italy Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
5.5.1.14. Italy Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
5.5.1.15. Italy Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
5.5.1.16. Italy Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
5.5.1.17. Turkey Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
5.5.1.18. Turkey Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
5.5.1.19. Turkey Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
5.5.1.20. Turkey Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
5.5.1.21. Russia Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
5.5.1.22. Russia Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
5.5.1.23. Russia Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
5.5.1.24. Russia Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
5.5.1.25. Rest of Europe Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
5.5.1.26. Rest of Europe Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
5.5.1.27. Rest of Europe Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
5.5.1.28. Rest of Europe Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Equine Veterinary Therapeutics Market Outlook, 2019 - 2032
6.1. Asia Pacific Equine Veterinary Therapeutics Market Outlook, by Drugs, Value (US$ Bn), 2019 - 2032
6.1.1. Key Highlights
6.1.1.1. Anti-Infammatory
6.1.1.2. Anti-infective
6.1.1.3. Parasiticides
6.1.1.4. Others
6.2. Asia Pacific Equine Veterinary Therapeutics Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2032
6.2.1. Key Highlights
6.2.1.1. Oral
6.2.1.2. Parental
6.2.1.3. Topical
6.3. Asia Pacific Equine Veterinary Therapeutics Market Outlook, by Service, Value (US$ Bn), 2019 - 2032
6.3.1. Key Highlights
6.3.1.1. Diagnostic tests and Imaging
6.3.1.2. Physical Health Monitoring
6.3.1.3. Surgery
6.3.1.4. Vaccination
6.3.1.5. Others
6.4. Asia Pacific Equine Veterinary Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2032
6.4.1. Key Highlights
6.4.1.1. Veterinary Hospitals
6.4.1.2. Veterinary Clinics
6.4.1.3. Pharmacies and Drug Stores
6.4.1.4. E-commerce
6.4.1.5. Others
6.5. Asia Pacific Equine Veterinary Therapeutics Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
6.5.1. Key Highlights
6.5.1.1. China Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
6.5.1.2. China Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
6.5.1.3. China Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
6.5.1.4. China Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
6.5.1.5. Japan Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
6.5.1.6. Japan Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
6.5.1.7. Japan Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
6.5.1.8. Japan Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
6.5.1.9. South Korea Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
6.5.1.10. South Korea Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
6.5.1.11. South Korea Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
6.5.1.12. South Korea Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
6.5.1.13. India Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
6.5.1.14. India Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
6.5.1.15. India Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
6.5.1.16. India Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
6.5.1.17. Southeast Asia Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
6.5.1.18. Southeast Asia Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
6.5.1.19. Southeast Asia Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
6.5.1.20. Southeast Asia Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
6.5.1.21. Rest of Asia Pacific Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
6.5.1.22. Rest of Asia Pacific Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
6.5.1.23. Rest of Asia Pacific Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
6.5.1.24. Rest of Asia Pacific Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Equine Veterinary Therapeutics Market Outlook, 2019 - 2032
7.1. Latin America Equine Veterinary Therapeutics Market Outlook, by Drugs, Value (US$ Bn), 2019 - 2032
7.1.1. Key Highlights
7.1.1.1. Anti-Infammatory
7.1.1.2. Anti-infective
7.1.1.3. Parasiticides
7.1.1.4. Others
7.2. Latin America Equine Veterinary Therapeutics Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2032
7.2.1.1. Oral
7.2.1.2. Parental
7.2.1.3. Topical
7.3. Latin America Equine Veterinary Therapeutics Market Outlook, by Service, Value (US$ Bn), 2019 - 2032
7.3.1. Key Highlights
7.3.1.1. Diagnostic tests and Imaging
7.3.1.2. Physical Health Monitoring
7.3.1.3. Surgery
7.3.1.4. Vaccination
7.3.1.5. Others
7.4. Latin America Equine Veterinary Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2032
7.4.1. Key Highlights
7.4.1.1. Veterinary Hospitals
7.4.1.2. Veterinary Clinics
7.4.1.3. Pharmacies and Drug Stores
7.4.1.4. E-commerce
7.4.1.5. Others
7.5. Latin America Equine Veterinary Therapeutics Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
7.5.1. Key Highlights
7.5.1.1. Brazil Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
7.5.1.2. Brazil Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
7.5.1.3. Brazil Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
7.5.1.4. Brazil Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
7.5.1.5. Mexico Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
7.5.1.6. Mexico Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
7.5.1.7. Mexico Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
7.5.1.8. Mexico Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
7.5.1.9. Argentina Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
7.5.1.10. Argentina Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
7.5.1.11. Argentina Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
7.5.1.12. Argentina Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
7.5.1.13. Rest of Latin America Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
7.5.1.14. Rest of Latin America Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
7.5.1.15. Rest of Latin America Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
7.5.1.16. Rest of Latin America Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Equine Veterinary Therapeutics Market Outlook, 2019 - 2032
8.1. Middle East & Africa Equine Veterinary Therapeutics Market Outlook, by Drugs, Value (US$ Bn), 2019 - 2032
8.1.1. Key Highlights
8.1.1.1. Anti-Infammatory
8.1.1.2. Anti-infective
8.1.1.3. Parasiticides
8.1.1.4. Others
8.2. Middle East & Africa Equine Veterinary Therapeutics Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2032
8.2.1. Key Highlights
8.2.1.1. Oral
8.2.1.2. Parental
8.2.1.3. Topical
8.3. Middle East & Africa Equine Veterinary Therapeutics Market Outlook, by Service, Value (US$ Bn), 2019 - 2032
8.3.1. Key Highlights
8.3.1.1. Diagnostic tests and Imaging
8.3.1.2. Physical Health Monitoring
8.3.1.3. Surgery
8.3.1.4. Vaccination
8.3.1.5. Others
8.4. Middle East & Africa Equine Veterinary Therapeutics Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2032
8.4.1. Key Highlights
8.4.1.1. Veterinary Hospitals
8.4.1.2. Veterinary Clinics
8.4.1.3. Pharmacies and Drug Stores
8.4.1.4. E-commerce
8.4.1.5. Others
8.5. Middle East & Africa Equine Veterinary Therapeutics Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
8.5.1. Key Highlights
8.5.1.1. GCC Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
8.5.1.2. GCC Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
8.5.1.3. GCC Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
8.5.1.4. GCC Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
8.5.1.5. South Africa Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
8.5.1.6. South Africa Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
8.5.1.7. South Africa Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
8.5.1.8. South Africa Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
8.5.1.9. Egypt Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
8.5.1.10. Egypt Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
8.5.1.11. Egypt Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
8.5.1.12. Egypt Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
8.5.1.13. Nigeria Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
8.5.1.14. Nigeria Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
8.5.1.15. Nigeria Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
8.5.1.16. Nigeria Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
8.5.1.17. Rest of Middle East & Africa Equine Veterinary Therapeutics Market by Drugs, Value (US$ Bn), 2019 - 2032
8.5.1.18. Rest of Middle East & Africa Equine Veterinary Therapeutics Market by Route of Administration, Value (US$ Bn), 2019 - 2032
8.5.1.19. Rest of Middle East & Africa Equine Veterinary Therapeutics Market by Service, Value (US$ Bn), 2019 - 2032
8.5.1.20. Rest of Middle East & Africa Equine Veterinary Therapeutics Market by Distribution Channel, Value (US$ Bn), 2019 - 2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. by Service vs by Route of Administration Heatmap
9.2. Manufacturer vs by Route of Administration Heatmap
9.3. Company Market Share Analysis, 2024
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Merck Animal Health
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Affymetrix
9.5.3. Elanco Animal Health
9.5.4. Zoetic (Pfizer Animal Health)
9.5.5. Equine Health UK
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Merck Animal Heath
  • Affymetrix
  • Elanco Animal Health
  • Zoetis (Pfizer Animal Health)
  • Equine Health UK

Methodology

Loading
LOADING...

Related Topics

Related Reports

Veterinary Drug Market by Drug Type, Animal Type, Route of Administration - Global Forecast 2025-2030 - Product Image

Veterinary Drug Market by Drug Type, Animal Type, Route of Administration - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028 - Product Image

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • 132 Pages
  • Europe
From
MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028 - Product Image

MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028

  • Report
  • 98 Pages
  • Africa, Middle East
From
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course (November 4, 2025) - Product Image

A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course (November 4, 2025)

  • Conference
  • 1 Day
  • Global
Veterinary Software Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Veterinary Software Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 167 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.